Key Word Submission Number(s)

(2R,6R)-hydroxynorketamine P159, P231, P243, P249

(R,S)-ketamine P149, P202, P215, P245, P249, P255, P600

(R,S)-ketamine infusion therapy P723

(S)-Norketamine P159

[11C]CPPC P443

[11C]fentanyl P306

17-β-estradiol P1

1H MRS P820

22q11 deletion syndrome 27.2

22q11.2 deletion syndrome P587, P825

2-AG P126, P434, P436, 46

5-HT1A receptor P597

5-ht1b P691

5-HT2A and 5-HT2C receptor pharmacology P497, P510

5-HT2A receptor P87, P698, 19.1, P681, 49.2

5HT4R agonist P628

5-MeO-DMT P707

5-methoxy-N,N-dimethyltryptamine P684

7 Tesla fMRI P887

7q11.23 copy number variation P518

7q11.23 Duplication syndrome P518

7T MRS P554, P831

7-Tesla P165

ABCD Study P6, P5, P10

abstinence P642

Academic / Industry collaboration 13

academic performance P10

acamprosate P749

accelerated aging P507

Accelerated iTBS P605

accumbens P412

acetate P152

Acetylcholine P504, P323, P818, P874

Acetyl-L-carnitine LAC P139

Acid-sensing P709

action potentials P346

Action-outcome associations 20.5

activated microglia P378

Active Avoidance P32, P484, P488, P659, 41.1, 41.2

activity-dependent regulation P407

Activity-regulated cytoskeletal associated protein (Arc) P751

Acute agitation P882

Acute and Chronic Stress P241, P881, 12.4

Acute effects 21.2

Acute Stress P54, P277, P656, P695, P761, P875, P887, P888, P889, 36.2, 46.3, 46.4, 51.4

Acute Traumatic Stress P67, P710, P864

Adaptive immunity P740

Addiction P347, P399, P190, P374, 1.1, 13.3, 29

addiction circuitry P355

Addiction comorbidity P414, P702

Addiction phenotypes P314

Addiction Severity Index 1.2

addiction susceptibility P482

Addiction-like behaviors P404

Addictive behavior P338

adenosine triphosphate (ATP) P264

ADHD P91, P135, P177, P554, P636, P637

adjunctive treatment P230, P232

Adolescence P3, P4, P7, P9, P18, P25, P77, P97, P270, P325, P391, P706, P856, P886, P891, P896, P10, P405, 3.4, 39.1, 39.2, 44, 44.2, 54.2

Adolescence- Critical Period P141, 4

Adolescent P280, P334, P442, P450, P551, P611, P902, P273, P353, 3.3, 35.3, P274

adolescent alcohol exposure P410

Adolescent Brain and Cognitive Development Study P269, P350, 11.2, P529, 4.5

adolescent cannabis 21, 21.5, P447

Adolescent Depression P218, P903, 33.3

Adolescent PTSD P730

adolescent stress P884

adrenergic receptor P483

adult hippocampal neurogenesis P244

Adult smoking and alcohol traits P80

advantages of the combination of therapies P811

adverse childhood experiences (ACE) P592

Adverse life experiences P24

Affect Regulation P725, 39

affective behavior 27, 44.4

affective components of pain 15.3

affective disorders P132, P617, 39

affective instability P770

affective neuroscience P184

affective touch P489

African Americans P440

age differences P819

Age of Onset P129

Aggression P32, P31, P380

Aging P500, P807

aging, disease course P826

Aging; Cognition; P571

Aging; Cognition; Stress; Acetylcholinesterase; Splice Variants P154, P502

agitation P161

AI P35, 22

Air Pollution P852

Alcohol P107, P181, P288, P303, P321, P340, P365, P388, P389, P396, P399, P555, P756, P273, 29, 34, 42

Alcohol Abstinence P335

Alcohol and substance use disorders P80, P157, P307, P319, P349, P370, P552, P663, 1.1, 13

Alcohol consumption P282, P346, P382, P395, P402, P429, P582

Alcohol dependence P275, P647, 34.5

alcohol drinking P303, P596

Alcohol intake P380, 13.4

Alcohol response P299

alcohol self-administration P339

Alcohol use P324

alcohol use disorder P14, P172, P272, P279, P389, P397, P401, P413, P428, P649, P299, 10.4

Alcohol Use Disorder - Treatment P296, P337, P356, P364, P369, P378, P428, P749, 10, 13.2

Alcohol use disorder and drug addiction P323

alcohol withdrawal 29.3

Alcoholic Liver Disease P282

Alcoholism 34.2, 34.3

Alcohol-seeking behavior P339, P377

algorithmic bias and fairness P722

Algorithms to improve clinical outcomes 6

allopregnanolone P164, P750

allosteric modulator P142, P818

alpha 1a, alpha 1b, 5-HT1A, and 5-HT2A receptors P561

Alpha-Adrenergic P561

Alzheimer's dementia P503

Alzheimer's Disease P98, P465, P498, P504, P510, P511, P43, P154, P262, P496, P509, P29, P512, 32

American Indian P176

Amphetamine P764, P174

Amygdala P32, P105, P156, P280, P475, P574, P615, P617, P618, P619, P667, P709, P766, P479, 28.2, 37, 37.2, 37.3, 50.3, 54.3

Amyloid beta P564

Anandamide P126, P433, P543, P730

Anesthesia-induced dreaming P94

anger P729

Anhedonia P451, P25, P238, P698, P703, P740, P762, 39.2, 39.1

animal model P762

Animal Models P150, P380, P439, P507, P514, P762, 17, 17.2, 45.4

animal to human translation 35

Anorexia nervosa P419, P417, P418, P420, P422, P425, P570, P693, 53.3

Anterior Cingulate Cortex (ACC) 20.3, 20.5, 36.5, 50.3, P146

Anterior Hippocampus P464

Anterior insula P27, P289

anterior prefrontal cortex P752

Anti- Amyloid Treatment 32

Antidepressant P34, P95, P208, P214, P243, P254, P634, 48.3, 48.5, P215, P233, 49.3, 6.4, P216

antidepressant mechanisms 45.2

anti-depressant response 49.3

antidepressant therapies 19

antinociception P18, P150

Antipsychotic P153, P434, P793, P796, P805, P441

Antipsychotic drugs P138, P678, P812

Antipsychotic response P835

Antipsychotic Treatment 17.2, 32

Antipsychotic Treatment Practice P652

antipsychotic-induced metabolic dysfunction P579

Antipsychotic-naïve first-episode psychosis P165, P820

Anxiety P47, P48, P50, P51, P54, P55, P57, P58, P59, P60, P106, P107, P383, P437, P576, P598, P718, P22, P144, P776, 28.2, 33, 33.2, 33.3, 33.4, 41, 41.1, 41.3, 49.2, 36

Anxiety & PTSD P439, P713

Anxiety and Depression P97, P186, P234, P242, P594, P683, P691, 38.3, 41.4

Anxiety and stress P53, P335, P483, 5

Anxiety circuitry P552

Anxiety development P522

anxiety disorders 33.1

anxiety-like behaviors P49

Anxiety-related behaviors P891

Anxiety-related circuitry P57, P574

Anxious Depression P603

Apoptosis P134

appetite P560

Approach/Avoidance P117, P481, P567

Approach-Avoidance Conflict P754, P735, 36.3, 41.3

archives 2

arketamine P293

artificial intelligence P39, P42, P46, 6.4, 22.1, 22.3

ASD P93

ASL P179

Astrocyte P241, P450, P451

astrocyte-neuron interaction P495

Astrocytes P447, P448, P312, P365, P444, P446, P573, P881, 12.4, 30, 30.2

astrogliosis P236

Atlasing P667

Attention P162, P177, P530, 37.5

Attention Deficit Hyperactivity Disorder P529

attentional bias modification 14.4

Attenuated psychosis syndrome 17

Auditory Brainstem Response P145

Auditory fear conditioning 5.4

Auditory Mismatch Negativity P794, P825, P848, 11.3

Auditory system P145

Auditory Thalamus P816

Autism P449, P520, P524, P527, P530, P525, 23.4

Autism Spectrum Disorder P29, P190, P514, P517, P868, P78, P513

Autism spectrum disorder and related syndromes P519

Autoantibody P585, P593

autobiographical memory P619, P715

Autoimmune encephalitis P585, P593

Automated natural speech analysis P46, P268, P795, 7.3

automated text analysis 1.2

autonomic nervous system P427, P724, P747

autophagy P776

aversion P340, P653, P765, P775

Aversive Learning P391, P484, P659, 50.3

Aversive Motivation P391, P448

avoidance 41, 41.4

avoidance learning P463

backtranslational 29.5

Bariatric Surgery P424

Basal Ganglia P374, P656, P813

Basmisanil P213

basolateral amygdala P20, P289, P377, P481, P483

BDNF P130, P173, 54.3

bed nucleus of the stria terminalis P469, P488, P887, P410, 41.1

Behavior P64, P78, P451, P468, P713, P63, 27.1

Behavioral Activation P239

Behavioral characterization P381

behavioral economics P301

behavioral flexibility P771

behavioral genetics P271, P314

Behavioral Model P673

Behavioral Pharmacology P421, P635, P673, P688

Behavioral Phenotyping P267

Behavioral Tasks P71, P420

Belief Updating 43.1

benzodiazepines P59

beta-amyloid peptide 1-42 P509

BHV-7000 P623

BI 1569912 P219

Biased signaling P499, P631

big data analysis 4

Binge alcohol use P372

binge drinking 51.3

Binge eating P416, 53.2

Binge Eating Disorder P421

binge-like eating P494

Biobank P532

Bioenergetics P264

Bioequivalence and Bioavailybility P687

Bioinformatics P218

Biological definition of psychiatric disorders P191

Biology of aging P204, P501, P863

Biomarker P95, P194, P199, P229, P554, P661, P80, P402, P93, 4.5

Biomarker Candidates P91

biomarker development P759

Biomarker Prediction P104, 39.2

Biomarkers P396, P84, P107, P826

biomarkers, neuromarkers P102

biophysical modeling P806

biostatistics P109, 52

biotyping 47

Bipolar P623

bipolar and unipolar depression 38.2, 39.2

Bipolar Depression P130, P898, P100, P222, P238, P573

Bipolar Disorder (BD) P109, P111, P113, P114, P118, P119, P120, P122, P123, P125, P126, P129, P131, P133, P134, P136, P172, P192, P369, P382, P442, P546, P551, P573, P679, P861, P98, P640, 26, P201, P897

Bipolar Disorder, fMRI P117, P121

Bipolar I Depression P116, P127

Bipolar I disorder P46, P112

birth cohort P572

blood biomarker P910

Blood Pressure P793, P111

Blood-Brain-Barrier P251, P378, P588, P834, P908, 27, 27.1, 27.2, 27.3

BNST P335, P474

Body dysmorphic disorder P266

Body size estimation P266

body weight P560

BOLD fMRI signal P51, P179, P426, P551, P571

Borderline Personality Disorder P30, P619, P676, P725, 37.2

Brain 34

brain aging P446, P536, P720, 3.4

Brain Based Markers for Depression P247

Brain Circuits P71, P295, P690

Brain Connectivity P582

brain connectome P746

Brain delivery 49

Brain development P1, P103, P269, P350, P427, P514, P572, P298, P767, 29.2, 42.4

brain epigenomics P355

brain imaging P8, P585

brain imaging, fMRI 37.4, 43.3

brain insulin action P579

brain microvascular endothelial cells P251, 27

brain networks P553, 4.2

Brain organoids 12.5

Brain plasticity 20.4

Brain regulation of metabolism P701

brain stimulation P291

Brain Stress 12

Brain structure 34.5

Brain Tissue 34.3

Brain transcriptomics P5, P798, 12.2

Brain-Behavior Relationships P560, P581, P879, P799

Buprenorphine P351

bupropion P285

C57BL/6 P77

Ca2+-permeable AMPA- type glutamate receptors P66

CA3 metaplasticity P249

Caenorhabditis elegans P467

calcium imaging P221, P254, P377, P446, P468

calcium-permeable AMPA receptors P328

cAMP signalling P564

cancer P441, P511

Cannabidiol P519, P528, P535, P643

cannabinoid P325, 40, P392, P642

cannabinoid receptor type 1 P432, P633

Cannabis P383, P780, P352, P367, P431, P452, P525, P621, P642, P847, 21.2, 40, 46.3

cannabis use P24, P124, P381, P457, P621, P4, 21.3, 23.2

cannabis use disorder P304, P728, P363, 21, 21.4, 23.3, 46

Cannabis Withdrawal P363

Cannabis-Tobacco Co-use 29.2

cannflavins P525

Canonical Correlation Analysis (CCA) P781

Cardiovascular P796, P905

cardiovascular function P680

cariprazine P56, P127, P629

Cartpt 24.4

catatonia P677, P678

Catecholamines P637

causal discovery analyses P319

causal reasoning P626

CB1 receptor P439

CBD P107

CBT 14.2, 33, 33.1

CBT and antidepressants 6.1

Celecoxib P120

Cell adhesion molecule P348, P457

Cell- and Circuit-selectivity P492

cell model 12

Cell-type diversity 42.4

cell-type specific 24.3

Cell-type specific transcription P375, P537, 24.2

Cellular P913

Cellular metabolism P357

Centanafadine P637

central amygdala P18, P482

central nucleus of the amygdala 3.1, 50.2, P62

cerebellum P1, P487, P838, P846

Cerebral Blood Flow P111, P546, P572

cerebrospinal fluid P590, 34.2

Cerebrovascular integrity P508

Cerebrovascular Reactivity P551

cFos P27, P473

c-Fos-expressing ensembles P295

CGRP P305

Chemogenetics P321, P62, P394, P480, 36.3, 50.4

chemokine P401

child maltreatment 3.3, 37.3

Childhood Adversity P11, P118, P887, 27.4

Childhood trauma P14, P23, P309, P724, P730, P830, 35.3, 35.5

Childhood-onset schizophrenia P828

Children P2

Children and Adolescents P64, P644, P903

cholecystokinin P361

cholinergic function P481

cholinergic interneuron P651, P753, P810

Cholinergic system P500

choroid plexus 34.2

chromatin 18.3, 24.2

chronic pain P58, P69, P403, P489, P545, P596, P664, P776, 20.3, 15

chronic pain treatment P348, P608

Chronic social and non-social stress P756

Chronic social defeat stress P894

Chronic social stress P27, P207, P246, P398, P752, P883, P893, 27, 51.4

chronic stress P188, P275, P451, 5.2

Chronic unpredictable mild stress P880, P890, P892

Chronic variable stress 10.2

chronotype P10

cilia P143

cingulate cortex P517

cingulotomy 20, 20.2

cingulum 20.2

circadian P318, P857

circadian function P124

circadian rhythm P128, P134, P267

circadian rhythms P415, P773, P859, P863, P146, 38, 54.2

Circuit 42, 50

Circuit Development P453, 18.2

circuit optogenetics P377, P474, 51

circular RNA 49.5

Circulating cell-free DNA P258

Circulating cell-free mitochondrial DNA P199

Citicoline P369

Claims database P257

claustrum P494

Clinical P672, 8

clinical assessment P39, P558, P797

Clinical Development P116

clinical efficacy P171

Clinical heterogeneity P118, P792

Clinical high risk state for psychosis P784, P801, 4.4, 11.5, 30, 30.3

Clinical high-risk for psychosis P35, P38, P550, P788, P789, P794, P795, P824, P833, P848, P851, 11.4, 17.4

Clinical high-risk of psychosis 11

Clinical Neurobiology P733

clinical neuroimaging research P60, P406, P540, P830

Clinical outcome assessments P788

Clinical practice P131, P458

clinical prediction 22.3, 39.3

clinical psychopharmacology P693, P912

Clinical Stability P115

Clinical trial P160, P163, P170, P173, P411, P594, P621, P649, P692, P726, P239, P230, P232, P248, 5.5, 10.3, 14.5, 33.4

Clinical Trial Methodology P109, P110, 13

Clinical trial, Data quality, Schizophrenia, Within Person Variance P38

clinically-ascertained samples P562

Clozapine P782, P524

CNS Clinical Trials P210, P851

CNS Radiotracer P300

CNTNAP2 P868

CNV P568

coactivation pattern analysis P806

Cocaine P375, P62, P290, P343, P353, P407, P408, P411, P650

cocaine addiction 5.3, 24.4

cocaine reinstatement and taking P276

cocaine self-administration P357, P368, P753, P777

cocaine self-administration and reinstatement P284, P366, 5.2

cocaine sex differences P777, P778

Cocaine Use Disorder P482, P309, P332, P358

Cognition P61, P64, P71, P125, P162, P175, P177, P211, P220, P240, P500, P554, P641, P784, P827, P837, P846, P847, P879, P882, P322, P536, P599, 23, 23.3

Cognitive/behavioral flexibility P61, P190, P435, P880, 18, 18.2, 18.4, 48

cognitive aging P670

cognitive behavioral therapy 41.3, 48.3

Cognitive biomarkers P86, P531, P832

cognitive control P220, 48, 10.4, 37.2

cognitive control circuit 48.4

cognitive control network 14.2

Cognitive dysfunction 47

Cognitive Enhancement P503

cognitive flexibility P82, P156, P184, P470, P610

Cognitive Functioning P180, P529

Cognitive impairment associated with schizophrenia P832, P837

cognitive inflexibility P189

Cognitive Neuroscience P50, P309, P406

Cognitive performance P23, P502, 21

Cognitive test P759

cognitive-behavioral therapy P534, P574, 14.3

Combat PTSD P729

Comorbidity P172, P277

Comparative effectiveness P110

Compulsive behavior P78

Compulsivitiy P321, P654

Computational Cognitive Neuroscience P186, 43.1, 53.2

computational ethology P69

computational linguistics 7.3

Computational Methods P530, P549, P654

computational modeling P193, P422, 7.5, 11.3, 48.2

Computational Neuroscience P192, P194, P320, P665, 11.4, 11.5

computational phenotyping 7

computational psychiatry P187, P610, 11, 22.2, 47.5

Computational Reinforcement Learning Model P475, 44.3

Computer vision 7.3

Computerized Cognitive Training 32

COMT Val158Met P158

concussion P8

conditioned place preference P278, P287, P409, P472

conditioned taste aversion P70, P289

Connectivity P800

Connectivity gradients P662, P715

Contraceptive use P676

coordinated specialty care P791

copy number variant P825, P532

Correctional Psychiatry P666

cortex P273

Cortical brain structures P125

Cortical GABA P633, P820

Cortical inhibition 45.4

Cortical maturation P5

Cortical microcircuit processing P700

cortical plasticity P817, 45.3

cortical thickness P568, P834, 21.5

corticosteroids 12.5

Corticotropin-releasing factor (CRF) P243, P275, P761

Corticotropin-Releasing Hormone P656

Cortisol P11, P889, P909

cortisol awakening response P540

Cortisol response to stress P11, P888

Cost-effectiveness, P217

COVID-19 P140, P236, P507, P214, 25

COX-2 Inhibitor P130

CpG Methylation P459

craving P102, P285, P345, 13

CRF P62

CRH+ neurons P32, 3.1

CRISPR P483

CRISPR/Cas9 P765

cross species 44

cross-species translation P322

CRP P824

cry P36

CSF 34

CSF Biomarkers 34.4

Cue Reactivity P389, P545, 13.5

cue-induced craving P324, P371, P389, P390, P545, P604

cue-induced-reinstatement P394

cue-reactivity P354

cultural psychiatry P896

Culture P176, P580

cytokines P245

Cytomegalovirus P588

D1 dopamine receptors P632

D1+ islands P151

D2 dopamine antagonists P153, P812

D2 dopamine receptor P651, P757, P786

D2 medium spiny neuron P627

D-amino acid oxidase inhibitor P501

data reduction P789

Data sharing 2

DCE MRI P908

d-cycloserine P196

Decision Making P180, P304, P430, P475, P758, P889, 22.1, 43.3, 44

Decision tree P217

deep brain stimulation P607, P610, 20, 28.4

Deep Brain Stimulation; Mood; Anxiety; Resting State, Functional MRI 20.4

Deep learning 7.2, 7.5, P40

Default mode network (DMN) P291, P614, P715

defensive and motivated behaviors P709, P890, 50

delay discounting 38, 38.1

Delirium P104

delta opioid receptor 15.3, P155

delta9-tetrahydrocannabinol P457, P528

Delta-beta coupling P103

Delusions P193

Dementia P43, P98

Dementia-related psychosis P510

dendrites P141

Dendritic spines P386

dental pain P669

dentate gyrus P192, P244, P254

Dependnence P356

Depression P4, P79, P83, P87, P106, P113, P140, P170, P183, P190, P198, P199, P205, P212, P213, P214, P220, P222, P224, P225, P228, P231, P237, P246, P250, P251, P253, P255, P259, P260, P262, P264, P367, P451, P456, P598, P602, P606, P608, P611, P625, P689, P698, P718, P740, P894, P906, P144, P227, P538, P750, 14.3, 3.2, 6, 7, 10.3, 10.4, 10.5, 15, 22.3, 28.2, 28.5, 33.4, 41.3, 45.1, 45.2, 48.2, 48.3

depression and obesity P424

depression and/or anxiety P458

Depression Inflammation Cytokine 3

Depression model P223

Depressive Mood P226, 34.5

depressive symptoms 6.2, 6.3, P140

Development 15.5, 42

developmental origins P747

Developmental Psychopathology P6, 39

Developmental trajectory P522

dexmedetomidine P161

diabetes P537

Diagnosis P39, P41, P44

diagnosis, psychopathology, dimensions, P828

dietary interventions P819

Diffusion Imaging P521, 20.2

diffusion MRI P69

Diffusion Tensor Imaging (DTI) P8, P578, P589, P612, P821, P508

diffusion tractography P132

diffusion weighted MRI P471

Digital avatar P266

Digital Biomarkers 7.2, 47.2

Digital phenotyping P38, P133, P136, P265, P267, P268, P703, 39

digital psychiatry P39, 47.5

Digital therapeutics 47, 47.4, 47.5

Dimensional child psychopathology P5

dimensional psychopathology P108, P187

discrimination learning P469

Disinhibition P338

disorders of gut-brain interaction P634

Dissociation P725, P731, 37, 37.2, 37.3, 37.5

Dissociative Subtype 37.4

Diversity and Inclusion 52, 16

DMT P160

DNA breaks P327

DNA damage response P327

DNA Methylation P630, P897, P98, 24.2

DNA, whole-genome, sequencing, schizophrenia P460

Dopamine P72, P153, P227, P292, P295, P326, P333, P374, P409, P434, P435, P447, P484, P520, P650, P735, P758, P762, P771, P808, P820, P875, P813, 8.1, 5.2, 33.3

Dopamine (D2, D3) receptors P499, P652

Dopamine circuit P625

dopamine D3 receptors P629

Dopamine D4 receptor P302

dopamine partial agonist P56, P812

Dopamine, Acetylcholine P651, P769

Dopamine3 receptors P138

Dopaminergic neurons P444

Dopaminergic system P741, P759

Dorsal anterior cingulate cortex 20.3

Dorsal Hippocampus P152, P470, P472, P741, P778

Dorsal premammillary nucleus 50.4

dorsal raphe P54, P453, P523, P765, 15.3

Dorsal striatum P92, P323, P435, P514, P810, P874

dorsolateral prefrontal cortex (DLPFC) P569, P649, P719, P737, P861, P863, P182

Down Syndrome P504

DREADD P27

DREADDs P20, P778

Drosphila melanogaster P496

drug addiction P281

Drug choice paradigm P368

Drug Discovery - new approaches P627

drug discovery/development P252, P632, P674, P672, P640, P672

Drug metabolism P644

Drug Relapse P276, P472

drug self-administration P381, 29.4

drug side effects P699

Drug use disorders P320

drug-drug interaction P362, P644

D-serine P501

DSM P44, P108

DSM-5 P677

DTI P240, P298, P830

DTI-ALPS P508

Dual Diagnosis P663

Dual Orexin Receptor Antagonists P332, P345

dynamic causal modeling P487

dynamic effective connectivity P658

Dynorphin P333, P404, P491, P494, P763, 15.2

dyskinesia P597

early adolescence P350

early brain development P48

early detection P797

Early Identification of Risk P6, P121

Early intervention P851

early intervention services P791

Early life adversity 18, 24.3, 35.2, P21, P16, 27

Early life stress P3, P17, P19, P27, P380, P755, P886, 3, 18.1, P351, P15, P18, P26, P885, 12.4, 24, 31.4

early psychosis P132, P195, P799, P807, P809, 30.4

early-life adversity 3.1, 18.3, 44.4, P25

eating behavior P429

Eating disorders P194, P266, P417, P420, P570, P693, P423

E-Cigarette P274

ecological momentary assessment P9, P181, P715, P770, 39.3, 53.2

education P458

EEG P71, P104, P229, P635, P804, P815

EEG biomarkers P42, P79, P87, P90, P103, P136, P682, P94, 6, 11.3, 37.2

EEG electrophysiology 19.4

EEG/ERP electrophysiology P794

EEG-fMRI P166

Effective Connectivity P242

efficacy P812

Effort P182, P769

effort based decision making task P530

Effort Discounting P761

e-field modeling P556

electric field modeling P620, P616

electroconvulsive therapy P202, P209, P224, P240, P244, P599, P620, P217

Electroencephalography (EEG) P519, P578, P609, P622, P731, P772, P825, P848, P817, 6.2, 6.3, 11.3

electron microscopy P452

electrophysiology P185

E-Liquid P274

EMA P319, P904

emergency medicine P912

emotion P430, P815

Emotion Circuitry P26, P731

Emotion Perception P548

emotion regulation P869

emotional arousal P51

Emotional dysregulation P427, P429, P893

Emotional Eating 53.1, 53.2

emotional memory P618

Emotional Meta-Awareness P178

emotional pain 20.3

emotional reactivity P427

Emotional regulation P73, P82, P385, P426, P428, P431, 53.3

Emotional stress 5.3, 27.3, P149

employment P669

encoding P618

endocannabinoid P341, P439, 46.3

Endocannabinoid System P566, P114, P438, P712, 5.2, 5.3, 46.4

Endocannabinoids P432, P435, P437, P438, P543, P596, P730, P775, 5, 5.4, 5.5, 46.2

endocrine biomarkers P592

endogenous opioids P765, 8.3, 43.2

endophenotype 38.1, P455

Endpoint Reliability 13.2

energy metabolism P596

engram P67

ENIGMA Working Group P563, P568

enkephalin P155, 15.3

enrichment P471

enteroendocrine cell P361

entorhinal cortex P500

Entropy P539

environmental contaminants P16, P49

epidemiology P442, P678, P896, P45, 29.5, 52

Epigenetic P886, P22, 18, 18.3, 31.3

Epigenetic Aging P148, P98

Epigenetic biomarkers P299, P885, P910

Epigenetic clock P112

Epigenetic editing 24.4

Epigenetic Modification 24.3

epigenetic regulation P144

Epigenetics P17, P139, P250, P355, P366, P400, P465, P548, 24, 31

epigenomics P235, 24.5

episodic memory P181, P618, P462

Epitranscriptomics P250

error processing P604

errors 41.4

escitalopram P437

Esketamine nasal spray P171

Essential oils P259

Estradiol P462, P292

Estrogen P676

estrogen receptor P276, P533

estrogen receptor beta P23

estrogen synthesis P282

ethanol P289, 46.2

event-related potential 41.4, 41

evidence-base assessment P226

Evoked gamma-band response P831

EWAS P630

excitatory/inhibitory balance P831

Excitatory neuron P74

executive function P188, P189, P307

exercise P465, P541

Expectancy P110, P382, 43.1

expectation 43.4

experience sampling methodology P856

experimental design P746, 25

Experimental Therapeutics 19.2

exploration-exploitation tradeoff P182, P770

explore-exploit dilemma P185

exposome P64, P515, P852, 25

Exposure therapy 33.2, 36.4

expression quantitative trait loci (eQTLs) P823

extended amygdala P282

extended-access self-administration P751

externalizing psychopathology P562

Extinction P281, P384

Extinction and Reinstatement P778

Extinction learning P414, P717

extracellular matrix P241

Extracellular vesicles P147, 31.4, 49

extrasynaptic glutamate P284

F-18 PET Imaging P505, P522, P733, P820

FAAH P433, P566, P730

FAAH inhibitor P543

face emotion 7.4

face emotion processing P804, P909

face expression 7, 7.4

Familial risk P135, P382

Family History P129

family history of alcohol use disorder P14

Fast-acting Antidepressant P173, 47.3

fatigue P256

Fear 50.4, P473

Fear conditioning P67, P748, 5, 5.5, 50, 50.2, 50.5

Fear conditioning and extinction P463, P707, P736, 35, 35.3, 54.3

Fear extinction 5.4, 36.4, P718

fear generalization 18, 18.1, P706

Fear learning 36.3, 42, 51.4, P702, P713

fear memory P471

Fear regulation P474, P710, 50.3

fear-potentiated startle P603

fecal microbial transplant P595

Feeding behavior 51.5, P485

Fentanyl P28, P278, P318, P336, P393, P763, P379, 51.2

Fentanyl Self-Administration P294, P301

Fentanyl withdrawal P294, P322

Fetal Fentanyl Syndrome P28

fiber photometry P495, P653

first episode psychosis P585, P626, 30

first episode schizophrenia P831

FKBP5 31.2

Fluid homeostasis 34.2

fluorine-18 P300

Fluornitrazene P311

fMRI P281, P296, P297, P354, P405, P408, P427, P569, P604, P714, P732, P736, P748, P779, P804, P847, P879, P906, 14, 21.2, 21.3, 41, 43, 4.2

fMRI Connectivity P566

fMRI Functional Connectivity P176, P613

fMRI, depression, rTMS, prefrontal cortex P256

fNIRS P542

focused ultrasound P52, P600, P609, P617, P618, 28, 28.2, 28.3, 28.4, 28.5

Folic acid P657

food craving 43.3

food cues P541

food intake P486, 53

food preference P63

food reward P408, 53.1

forgetting P471

fragile X syndrome P459, P531

free water P240

Free water imaging P843

Frontolimbic network P544

FTO P424

functional brain connectivity P405

functional brain network P544

functional connectivity P567, P744, P879, P829

functional constipation P634

Functional MRI (fMRI) P82, P102, P181, P286, P291, P309, P347, P406, P425, P462, P541, P543, P545, P548, P554, P581, P603, P658, P844, 37.3, P843, P813, 37.5, 41.3

functional neuroimaging 35.3, 48.4, 48.5, P789

Functioning P127, 23

Funding P913

G protein-coupled receptors P142

GABA P47, P179, P392, P550, P641, P771, P875

GABA and Glutamate P256

GABA neuron 42.4, P394

GABAA positive allosteric modulators neuroactive steroid P88, P99

GABA-A receptors P89, P101, P213

GABA-A, positive allosteric modulators P641

GABAergic interneurons P477, P700

GABAergic transmission P482

GAD P683

galanin P287

Gamma synchronisation P850

Gamma-band auditory steady-state response (ASSR) P794

Gap inhibition of Acoustic Startle Reflex P145

Gender differences P413

gene expression P152, P204, P329, P538, P640, P685, P745, P752, P137

gene regulation P237, P355

gene therapy 24.5, 27.2, 49.2

Gene x environment interactions 18.4

generalized anxiety disorder P52, P683, 33.2

Generative Artificial Intelligence P37, P44, P581, P797

Genetic biomarker P685

Genetic Disorder P516

genetic risk factor 42.5

Genetic variability P457, 38.2

Genetic variation P308, P897

genetics P201, P785, P786, 38

Genetics first P521

Genomics P100, P355, P454, P456, P803

Gestational stress P738

Gliotransmission P447

Globus Pallidus P495

GLP-1 P399

GLP-1 receptor agonist P223, P370, P393

GLT-1 P647

glucocorticoid P490

glucocorticoid receptor P237, P881

Glucocorticoids P630, P895

glutamate P139, P153, P165, P376, P550, P647, P675, P737, P841, 17.5

glutamate and gaba P35

Glutamate homeostasis P172

glutamatergic transmission P876

Glutaminase Inhibitors P894

gluten P819

Glymhatic clearance P675

glyphosate P49

GPCR P95, P143, 19.1

GPER1 P533

G-proteins P95

grid cell P466

guanfacine 48.4

Gut Microbiome P279, P308, P449, P595, 3.2

GWAS P356, P455, P461, 38.1, 38.3

habenula P424, P575, P658, P821

habit 13.4

habituation P616

hallucinations 43, 43.1

hallucinogens P681

HDAC P733

Head twitch response P660

Health Disparities P43, P270

Health Economics P671

Health Equity P440, 40

Health services P131

healthy individuals 8.2

healthy volunteers P684

heart rate variability P106, P724

Heroin P359, P412, P394

heroin seeking P312

heroin self-administration P312

Hi-C chromatin conformation P518

hierarchical cluster 29.5

high fat diet P317

High fat diet induced obesity P348

High-density lipoprotein P508

Hippocampal Complex P462

Hippocampal Function P466, P586

hippocampal hyperactivity; 17

hippocampal subfields P536, 18.2

Hippocampal-prefrontal 18.2

Hippocampus P139, P204, P235, P243, P254, P280, P465, P512, P559, P343, 17.4, 18.4

hippocampus subfields P502, 17.5

hippocampus, medial PFC P826

hIPSCs P234

Hispanic 16

Hispanic/Latinos P791

Histone acetylation P152, P218

histone deacetylase P548

HIV P23, P414, P592

HIV and Inflammation P590

HIV associated neurocognitive disorder P414

H-MRS 17.5

Hoarding Disorder P655

homeostatic plasticity P328

hospitalization P809

Hostile Interpretation Bias P708

hot flash P461

Human Clinical trial P109, P197, P260, P617, P686, P721

human epigenetics/microRNA P910

Human Genetics 26

Human Neuroimaging P37, P71, P119, P195, P385, P424, P502, P542, P547, P552, P563, P570, P661, P717, P835, P423, 4.4, 3.5, 5, 21, 47.3

human post-mortem brain P781, P250

Hyperactivity P128

hyperalgesia P288, P404

hyperarousal P716

hyperscanning P869

Hypnosis P601

hypocretin P855

hypothalamus P53, P710, P878, P886, 50.4

ibogaine P157, P682

Identical by descent P460

IL-1beta P584

IL1RAPL1 P460

IL-6 P120

Imaging-genetics P455

Immune P411

Immune Biomarkers P907, P592

immune cells P16

immune function 30.4

immune mechanisms P785

Immune surveillance 34

Immunity & neurodevelopment by sex P591

immunohistochemistry P327, P331

Immunometabolism P225, P762

Implicit association test P911

Impulsive behavior P2

impulsive sensation seeking 13.4

impulsivity P86, P136, P372, P636, P651, P912, P338, 13, 13.3, 13.4

in vitro cellular model P509

in vivo calcium imaging P470, P483, P488, P32, P754, 45.3

in vivo electrophysiology P493

In vivo fiber photometry P278, P434, P448, P651, P874, P878

In vivo Imaging P85, 18.1

Inattention P577

Incense sticks P65

incentive motivation P66

inclusion and exclusion P116

incubation of cocaine craving P328, P376

incubation of methamphetamine craving P371

incubation of oxycodone craving P315

incubation of sucrose craving P371

Indirect Pathway P493

individual differences P267, P702

individual variability P752

Individual vulnerability P404

individualized Low Amplitude Seizure Therapy (iLAST) P620

Induced pluripotent stem cells (iPSCs) P114, P154, P192, P231

Infancy P36, P103

Infant Brain P57, P73

Infant fMRI P526, P744, P247

infection P657

Inflamation P203, 3.3

inflammation P16, P23, P140, P148, P330, P351, P401, P705, P740, P762, P807, P824, P834, P857, P908, 27.4

inflammation in schizophrenia P819

Inflammatory Markers P822

informatics P44

Information Encoding 15.2

informed consent P696

inheritance 31, 31.3

Inhibitory control P414, P649

insomnia P401, P858, P864, P866

Insula P178

Insula Connectivity P429

insular cortex P486, P662

insulin resistance P670, P701

Integrated Dual Disorder Treatment P663

Intergenerational Transmission 31

intergenerational transmission of stress 35

Intergenerational transmission of trauma P714, P727, 31.2, 35.4

Intergenerational trauma 35.5

Interleukin 1beta P523, P802

Interleukin-6 P802

Internet survey P430

interneurons P479

interoception P709, P815, P194, 37.5, 43

Interoceptive Awareness P178

interpeduncular nucleus P47, P395

interpersonal violence P713

inter-rater reliability P96

inter-subject correlation P183

Intracerebral microdialysis P637

intracranial EEG P506

intravenous drug self-administration P305, P329, P760

Intravenous self-administration P62

intrinsic excitability P366, P412

intrinsic neural timescale P806

Ion channel P625

Ion channel activator P623

iPSCs P895

irritability P538, P575, P611

Irritability/Aggression P29, P524, P708, P906

iTBS P79, P198

IV- Ketamine P105, P694, P217, 48.2

jumping to conclusions P783

juvenile critical period 18.2

kappa agonist P631

kappa opioid receptor P478, P491, P645, P655, 15.2

Kappa Opioid Receptor Antagonist P68, P631

kappa opioid receptors P494, P631

KarXT P793, P796, P805

Kcnh2 P346

Kefir fractions P496

kefir peptide P509

Ketamine P69, P110, P159, P199, P222, P243

Ketamine/esketamine P209

Ketogenic diet P19, P317

Kynurenic acid P392, P583

Kynurenine pathway P106, P310, P860, P130, P898

L1 retrotransposons P755

lactate metabolism P572

language P188, P797, P577

Large Language Models P44, P795, P801, 7.2, 22, 22.1, 22.2

Laser Capture Microdissection P146

Late Life Depression P258, P599

Latent Factor Analysis P271

Lateral Habenula P349, P365, P393, P445

Lateral hypothalamus P485

lateral orbitofrontal cortex P880

Lateral Septum 42, 42.2, 42.3, 42.4, 42.5

Laterality P577

Later-life Depression P261

L-dopa induced dyskinesia P499

Learned escape 50.4

learning and memory P490, P76

Learning Health Network P123, P809

Learning Health System 26

legacies of stress 31.4

Leptin P486

Lesions P60, P558, P560

levodopa P597

lick microstructure P70

Lifetime stress P396

Light Therapy P415

limbic brain circuitry 53.3

limbic system P476

linear mixed models P562

Lipid metabolism P419

Liquid Biopsy P258

liquid chromatography/mass spectrometry P787

Lithium P912, P640

Lithium response P118

lived experience 1, 1.1, 26

liver brain axis P282

liver transaminase P805

local field potentials P607, P610, P709

locomotion P359

locomotor activity P128

Locus coeruleus P778

Locus coeruleus (LC) P559, 51.2

long noncoding RNA 49.4

Long-acting injectable antipsychotics P626, P849

longitudinal P273, P405, 21.5

longitudinal analysis 11.2

Longitudinal MRI P418

longitudinal multimodal imaging P48

longitudinal studies P115, P536

Long-term treatment P131

Losartan P55

lower-middle income countries P170, P790

LPS P892

LSD P687

L-type Voltage-Gated Calcium Channel P145

lumateperone P230, P232, P238

Lymphatics 34.4

machine learning P33, P34, P36, P41, P43, P102, P116, P195, P202, P209, P269, P313, P353, P389, P832, P45, P372, 1, 1.2, 1.3, 6.1, 6.2, 11.2, 21.4, 22.2, 39.3, 48.3

machine learning classification P68, P263, P377, 54.1

Machine learning clustering P42, P845

Macrophage P834

MADRS P197

Magnetic Resonance Imaging P37, P602, P843, P555, 34.2

magnetic resonance spectroscopy (MRS) P165, P737, P555, P35, 15.4

magnetoencephalography P26, P173, P245, P831, P909

Maintenance treatment P849

Major Depression P383, P263

Major Depression Disorder P170, P196, P201, P211, P233, P236, P241, P252, P542, P559, P606, P686, P719, 20, 27.3

Major Depressive Disorder (MDD) P42, P95, P100, P160, P163, P164, P169, P197, P206, P209, P235, P239, P553, P603, P759, P858, P908, P81, P162, P203, P257, P907, P230, P232, P238, 48.4, 12.2, 12.3, 6.1, 6.2, 6.3, 6.4, 10, 47.2, 53.1

Major psychiatric disorders P588

mania P113, P679

Markers of response P205

mast cells P140

maternal behavior P31, P539, p21

maternal brain P539

maternal caregiving P714

maternal immune activation P859, p447

maternal mental health P166

maternal separation P20, P741

maternal stress P31, P885, 18.4

Maximum entropy model P191

MCID P837

MDD P204, P210, P216, P219, P229, P623, 49.4

MDMA P438, P696, P871, P872, 10, 10.5

mebufotenin P684

Mechanistic Clinical Trial P690

medial entorhinal cortex P466

Medial Prefrontal Cortex (mPFC) P20, P221, P316, P371, P478, P492, P629, P768, P827, P881, 51.3, P469, P477, P754, P758, P760, P859, 15.2, 45.1

Medial temporal lobe P664

mediation analyses P121

Medicare P373

Medication adherence P257

Medication Assisted Treatment P694

Medication Development P364

medication-naive first episode psychosis 17.5

medium spiny neurons P151, P735, 51.4

MEG P183

memantine P174

Memory P281, P465, P501, P343, 49.5

Memory and Learning P215, P467, P472, P530

Memory Bias P181, P464, 47.3

Memory Consolidation and Extinction P469

Memory Encoding and Retrieval P571, 42.3

Memory engram cell P706

menopause P740

Menstrual Cycle P99, P101, P385

Mental Disorders P900, 4.2

Mental health disorders 1.1

Mental health outcomes P676

Menthol P440

Mesocorticolimbic system 5.2

mesolimbic reward circuitry P128, P357

meta-analysis P125, P364, P750, P811, P835, 33.1

Metabolic Biomarker P330

metabolic function P670

Metabolite Quantification P35

metabolites P93

metabolomics P537

Metabotropic glutamate receptor 2 (mGluR2) P648

Metabotropic glutamate receptor 3 (mGluR3) P827

Metacognition P406

metformin P284

methadone P373

Methadone maintenance treatment P310

Methamphetamine P438, P565

Methamphetamine Self-Administration P295, P301

Methamphetamine use disorder P285, P345

methylphenidate P281

mGlu 2/3 P244

mGlu2/3 antagonist P173

mice P72

Microarray P250

microbiome P63

Microbiota-gut-brain axis P517, 3

Microdialysis P629

Microdosing with psychedelics P680

microglia P207, P386, P443, P445, P450, P452, P453, P533, P586, P590, P894

microglia engulfment P449

microglia-neuron interactions 3.1

microRNAs P400

microscopy P452

midlife P188

mild cognitive impairment due to AD 49.2

Military P772

Mind & Body Approaches 37.4

Mindfulness Meditation P731

miniscope P393

minocycline P279

Mismatch Negativity P578

Mitochondria P15, P119, P139, P199, P200, P533, P858, 26

Mitochondrial DNA P858

Mitochondrial dynamics P315

Mitochondrial Respiration P738, P883

Mnemonic Discrimination P55

Mobile application P265

mobile sensing P133

model-free and model-based learning P78

Molecular P913

Molecular Genetics P459, P467

molecular mechanisms P304

Molecular Mimicry P593

monetary incentive delay task P658

Monoacylglycerol lipase P436

monoamine oxidase B P573

Monoamine Oxidase-A P200

monoamines P742

monoclonal antibodies P802

Mood P182, P867

Mood and anxiety disorders P901, 28

Mood and cognition P186

mood disorders P113, P128, P640, P905, P129, 12.4, 38, 47

Mood-related behavioral responses in rodents 10.2

Moral Injury P547

morphine P305, P317, P409, P472

morphological and resting state brain activity 52

morphometry P838, 34.3

mother-child dyads 35.4

motion processing P804

Motivation P75, P767, P339, 51, 15, 15.5

motor activity 38, 38.2

mouse P774

Mouse models P244, P267, P641, P776, 5.4

mPFC 49.4

MR imaging P85

MR spectroscopy P550

MRI P13, P83, P135, P156, P280, P664, P273, 3.4, 34.3

mRNA P583

mRNA translation P854

mtDNA P15

mTOR P371

mTORC1 P854

Mu opioid receptor P287, P293, P311, P400, P645, P767, 15.5, 50.5, P155, P326

multi-echo fMRI P602

Multi-modal imaging 30.4, P423

Multimodal Neuroimaging P73, P516, P549

Multi-omics P402, P587, P895, 12

multiple sclerosis P60, P595

Multiplex fluorescent in situ hybridization P137

Multiscale Neuroimaging 17.4

multivariate analysis P799

multivariate approaches, deep learning 47.2

multivariate pattern analysis P711

mu-opioid receptor agonist 15.4

mu-opioid receptors P300

Muscarinic M4 P635, P818

MVPA P736, P779

N-acetylcysteine P172, P884

naloxone 43.4

Naltrexone P285, P749

Nanoparticle Delivery Systems P600, P894

narcolepsy P865

native americans P580

natural language processing 7, 7.5

natural language processing (NLP) P41, P801, P828, P902, 7.3

natural menopause P188

Natural rewards P416, P757, P763

Negative Affect 39.3, 53, P410

Negative allosteric modulator of GABAA receptor P227

negative emotionality P14

negative reinforcement P484, P488

Negative Symptoms P158, P779, P824, P836, P167, 30.3, 47.4

neighborhood resources P12

Neighborhood Socioeconomic Deprivation P852

Neocortex P137

neonatal abstinence syndrome P68

neonatal opioid withdrawal P68

network analysis P628

neural circuits 3, 51, 18

Neural connectivity 14.4

neural heterogeneity P484

neural marker P113

Neural mechanism P313

Neural Mechanisms of hallucination emergence 11.4

Neural networks P487

neural plasticity 44.3

neural populations P468

Neural Reward Circuitry P347, P485, P766, 33.2, 33.3, 39.1

neural signature P33

Neural-derived extra-cellular vesicles 49.3

neurite architecture 23.4

Neuroactive Steroids P84, P89

neuroanatomy P814, 20.2

neurobehavioral disorders P19

Neurobiological effects P223

neurocognition P124, P532, 23.4

Neurocognitive functioning P255

neurodegeneration P503, P507

Neurodegenerative Disease P505, P594

neurodevelopment P12, P526, P535, P792, P870, P780, 14, 25, 4.4

Neurodevelopmental and psychiatric disorders P568

Neurodevelopmental Disorders P147, P477, P515, P516, P521, P532, 24.2

neuroeconomics P430

neuroendocrinology 42.3

neurofunction P351

Neurogenesis 12.5

neuroimaging P60, P300, P841, P122, 4.2, 14.3, 52

neuroimaging (VASO, 1H-MRS) P826

Neuroimaging Analysis P845

neuroimaging biomarkers P97, P668

neuroimmune 35.2

Neuroimmune communication P523

neuroimmune mechanisms P388, 3

Neuroimmunology P591

neuroinflammation P236, P310, P564, P570, P584, P587, P790, P589

Neurological disorders 49.5

Neuromelanin-sensitive MRI P96, P557, P808, P853

Neuromodulation P52, P606, P608, P769, 28

neuromodulators P665

Neuronal Activity P537

Neuronal ensembles P407, P22

Neuronal morphology P641

Neuronal Proteostasis 34.4

neuropathic pain P150, P673, 15.4

neuropeptides P54, P409, P876, 51.2, 42.2, 51

neurophysiology P138, 35

Neuroplasticity P7, P252, P688, 19.1, 19.3, 45

neuroplastogen P163, P698, P718, P726, 19.3

neuroprotection P134, P145

Neuropsychiatric Disorders P505, P674, 23, 38.1

Neuropsychiatric symptoms (NPS) P882

neuropsychology P184

Neuropsychopharmacology (NPP) P138, P674

Neuroscience P913

neurosteroids P538, P369

neurosurgery for psychiatric disorders 20.5

Neurotechnology P224

neurotensin P53, P142, P766, 51.5

neurotransmitters 27.1, 45.4, P746

Neurovascular 27.1

Neurovasculature 27.4

New anxiolytics P631

new drug development P348

next generation sequencing P258, 24.3

nicotine P361, P403, P274, 29

Nicotine addiction P297

nicotine dependence P354, P614

Nicotine exposure 29.4

nicotine/substance use disorder P334

nicotinic acetylcholine receptors P395, P777

NIH HEAL Initiative P643

NIH policy 2

NIMH P674

NIRS P869

Nitazene P311

Nitrous Oxide P546, P553

NLX-112 P597

NMDA Antagonists P169, P628, P210

NMDA modulators P622

NMDA Receptor P87, P208, P501, P593, 17.2, 44.2

NMDA receptor antagonist P233

NMDAR antagonist P553

NMDA-R antagonists 19.4

Nociceptin/orphanin FQ 42.2

nociception P433, 24

non-coding RNA 49.4, 49

Non-hallucinogenic P698

Nonhuman Primate Models P48, P368, P398, P522, P475, P774

noninvasive brain stimulation P609, P212, P286, 45.2,

Non-invasive Neuromodulation P182, P602, 28.2, 28.4, 28.5

Non-stimulant P636

Noradrenergic System P342, P390, P561

Norepinephrine P227, P445

Normative modelling P266

Nos1 P486

Novel coronavirus (SARS-CoV-2) P745

novel endpoints 13.5

novel methods P549

Novel Rapid Antidepressant P221, P638, 19.3, 19.4

Novel Targets 24.2

Novel treatment P625

NPSR1 51.2

NR2B NAM P219

Nr4a1 24.4

Nucleus Accumbens P207, P366, P375, P416, P475, P627, P653, P758, P766, P769, P775, P868, P873,, P326, P346, P753, P151, 18.3, 41.2, 54.2

nucleus accumbens core P328

nucleus reuniens P3

nutrition P666

NYX-783 P362

Obesity P66, P225, P541, P757, P865, 51.5

Obesity and eating disorders P421

observational fear learning 35.4

Observational learning 43.4

Obsessive Compulsive Disorder (OCD) P69, P607, P610, P656, P660, P662, P688, 20, 20.5, P661, 20.2, P162, P658, 22.1, 28.3, 33.1, P488, P654, P657, P659, 20.3, 22

Obsessive-compulsive personality disorders P901

Obsessive-compulsive personality traits P189, P729

Obsessive-compulsive symptoms 13.4

Olanzapine P579

older adults P265, P456

Olfaction P21, 31.4

olfactory bulb P13

olfactory cortex P664

Open Label Trials P617, P692

Operant behavior P495, P623

opioid P18, P166, P751, 29.4, 31, P292, P333, P431, P639, P774, P391, 8.1, 29

Opioid abuse P28, P314

Opioid addiction P72, P271, P327, P344, P386, P400, P432, 5.3, 8.2, 31.3

Opioid craving 13.5

opioid dependence P646

opioid overdose P336

Opioid peptides P342

Opioid side-effects P624

Opioid signaling P624, P646, 15

Opioid system P30

opioid tolerance P317

Opioid treatment P360

opioid use P387

opioid use disorder P58, P287, P291, P305, P308, P310, P329, P330, P351, P362, P373, P379, P390, P406, P415, P604, 13.5

opioid withdrawal P305, P341, P360, P387, P326

optical imaging P620

opto- chemogenetics P495

optogenetics P254, P343, P480

orbitofrontal cortex P490

orbitofrontal cortex (OFC) P315, P664, 51.2

orexin P333, P865

orexin receptor antagonist P63

orexin/hypocretin P860, P878

Organoids P154

orphan receptors P627

oscillations P479

OUD P283

outbred rats P271

overdose P639

Oxycodone P331, P362, 8.2

oxytocin P168, P175, P290, P342, P868

oxytocin and addiction P337

P300 P794

PACAP P335, P704

Pain P137, P288, P292, P410, P431, P433, P643, P672, P765, 8, 8.1, 8.3, 20, 36, 24.5, 36.5, 43, 43.2

pain models P857

Pain sensitivity P511, P576, P642, 43.4

Pain-induced depressive-like behaviors 15.4

panic disorder P277

parabrachial nucleus P335, P410, P489

Paranoia P783

paraventricular nucleus of the hypothalamus 3.1, 36.2, P887

paraventricular nucleus of the thalamus P25, P766, P862, P75, 41.2

paraventricular thalamus P645, P775

Parent - child dyads 14.5, 35

parenting P575

Parkinson's disease P499, P594, P597

Partial agonist Ligands P302

partner loss P883

Parvalbumin fast-spiking GABAergic interneurons P515

parvalbumin interneurons P859

Parvalbumin neurons P884

passive sensing P902

Paternal care 35.2

pathogenic mechanisms 17.3

pathophysiology 11

Patient Reported Outcomes P206, P216, 1, 1.3

patient-provider alliance P216

pattern separation P192, P55

Pavlovian conditioning P316, P702

Pediatric anxiety disorders 14, 14.2, 14.4, 14.5, 14.3

Pediatric Bipolar Disorder P115

Pediatric clinical trials P534, P574

Perceived stress P390, P747

periaqueductal grey (PAG) P404, P478, 43.2

Perimenopause P716

perinatal P750

perinatal depression P746

perinatal mental health P742

Perineuronal nets P386, P728, P751, P884, 44.3

Peripartum P886

peripheral nervous system P361

personality P307, P770, 38.3

personalized medicine P291, 6.3

personalized treatments P613, P615, P205

Pesticides P259

PET Imaging P236, P311, P358, P504, P548, P564, P566, P573, P712, 23.3, P40, P283, P436

Pharmacodynamics P159, P528, P687

Pharmacoepidemiology P59, P626

pharmacogenetics P456, P458, P644, P257

Pharmacogenomic-guided treatment recommendations P234, P458

Pharmacokinetics P159, P306, P497, P505, P528, P687

Pharmacology P632

pharmacotherapy P59, P341, P388

Phase 1 P164, P528, P362

Phase-amplitude coupling P104

Phosphodiesterase-4 (PDE4) P564

Physical exercise P502, 32

PKCdelta P321

Placebo Response 43, 43.2, 43.3, 43.4, 48.5, P228

placenta P147, P743, P745, P885

Plasticity P768

policy P558

Polydrug Use 21.4

Polygenetic Risk Score P529, P112, P792

Polygenic scores P14, P118, 18.4

polysubstance P376

polysubstance use P298, P301, P368, P398, 29.5

Poor clinical outcome P211

Population Health P123, P671

Population neuroscience 25

population-based samples P562

Positive Symptoms P816, P788

positive valence 33.4

Positron emission tomography P306

Positron Emission Tomography (PET) Imaging P30, P261, P263, P300, P310, P576, P652, P397, P561, 23, 23.4

Post Traumatic Stress Disorder 5, 12.3, P895

Postmortem P839

post-mortem brain P895, 12

Postmortem Brain Tissue P148, P253, P454, P498, P588, P719, P787

Postmortem Human Brain Tissue P146, P327, P667, P861, 42.5

postoperative cognitive dysfunction P675

postpartum P679

postpartum depression P84, P738, P739, P745

Postpartum mental health P526, P697, P714, P741

Postpartum Period P727

postpartum psychosis P557, P679

Posttraumatic stress disorder P563, P615, P616, P715, P727, P13

potassium channel P862

prairie voles P665, P873

prazosin P708

Precision Medicne neuropsychiatric diseases P319

precision psychiatry P108, P229, P205, 4.3, 6.2, 6.3, 47.2

precison mental health 1.3

Preclinical P672, 8

Preclinical Alzheimer's Disease P506

Preclinical and clinical studies P364

Preclinical assessments P259

preclinical cholinergic nicotinic receptors 29.3

Preclinical models and endpoints 19.2

Preclinical pharmacology P439

predator stress P53

Prediction error 44.2, 53, 53.2

Predictive Biomarker P542

Predictive Models P565

Predictor analysis P127

prefrontal circuit 45.2

prefrontal cortex P384, P452, P468, P476, P646, P738, P104, P871

prefrontal-amygdala-connectivity P473, 14.5

pregnancy P147, P724, P745, P747, P773, 29.2

pregnancy/postpartum P106, P749

Pregnenolone P369

Prelimbic Cortex P76, P70

Premature response P338

premenstrual dysphoric disorder P101, P303, P540

premenstrual syndrome P101, P303

Premorbid IQ; current IQ; cognitive subgroups; first episode schizophrenia 4

prenatal adversity P22

Prenatal Cannabis Exposure P320, P350, P743

prenatal depression, P744

Prenatal SSRI Exposure P634

Prenatal stress P891

Prescription Opioids 8

prevention P307

prevention by voluntary aerobic exercise 24.3

Prevention of Alzheimer's disease 4

Processing speed P162

Prodromal Psychosis P801

progesterone P395

Progressive ratio testing P480

Proinflammatory cytokines P324, 3.4, P378, P819

prolactin P441

protective factor P580

Protein Aggregation P498

Proteomics P262, P331, P402, P446, P498, P624, P807, 34

Psilocin P197

Psilocybin P205, P638, P681, P686, P689, P690, P691, P692, P696, P248, 10, 10.4, 36.2, 36.3, 36.4

Psilocybin analog P638, P697

Psilocybin therapy P693, 10.3

psychedelic P697

psychedelic drugs P160, P684

Psychedelic effects P707, 19.2

Psychedelic medicine P157, 36.4

Psychedelic therapy P197, P686

Psychedelics P87, P110, P231, P512, P594, P638, P660, P680, P681, P683, P685, P687, P688, P689, P691, P693, P695, P696, P700, P872, 248, 10.2, 10.3, 19, 19.1, 36, 36.2, 36.5

psychiatric genetics 38.3

psychiatric measurement P170, P226

Psychiatric Risk P57, 7.2

psychological distress P77

Psychological inflexibility P694

Psychopharmacology Treatment Guidelines 6.4

psychophysics P511

psychophysiology P431, P727, P815

psychosis P10, P179, P498, P614, P797, P840, P839, 4.2, 17.3, 36

Psychosis spectrum symptoms P822, P830, 11.3

psychosocial intervention P166

psychosocial stress P99, 53.1

Psychostimulant addiction P76, P348

Psychotherapy P193, P344, P694, P699, P705, P721, 7.5, 10, 33.2

Psychotic Disorders P846, 12.4

psychotic-like experiences 4.3, 4.5, 11.2, P852

PTSD P82, P94, P277, P344, P461, P543, P547, P608, P692, P701, P704, P705, P708, P712, P714, P716, P717, P718, P719, P720, P721, P722, P723, P726, P728, P732, P733, P734, P736, P737, P748, P864, P711, 5.4, 5.5, 7, 7.3, 10.5, 31.2, 37.4, 38.3, 46, 46.4, 54.1

Puberty P1, P544, 12.2

public health P12, P65, 40

punishment learning 36.3

Pupil Size P178

pyramidal neuron P798, P137

QTL P897

qualitative research 10.5

Quality of LIfe (QoL) P45, P683

Quantitative Electroencephalography (qEEG) P88

Quinolinic Acid P583, P898

racial discrimination P12, P26, P269

Racial minorities P429

Racial/ethnic differences P24

Racism 37.5

radiomics P263

Radiotracer P561

randomized clinical trial P364, P648

randomized controlled trial P811

Randomized Double-Blind P105, P390

Randomized-Controlled Trial P193, P228, P572

Rapid depression treatment P206

Rasopathies P521

Rat P274, P49, P317, P629

Rat models P591

Rating scales P677

RATTACA, P482

reading P12

Real World Data P108, P739

real-time fMRI neurofeedback 53, 53.3, P619

Real-world clinical outcomes P723

receptor binding P818

Receptor Occupancy P497

recognition memory P633

Recovery 1, 1.1

Reelin P407

Reinforcement learning P187, P297, P422, P770, P840, 44, 48, 48.5, 44.5

reinstatement P384

relapse P92, P353, P849, 47.2

relapse and treatment outcome P272

religion P896

remission P216

remote assessment solution P39

Renin angiotensin system P55

Repetitive transcranial magnetic stimulation P611

repetitive transcranial magnetic stimulation (rTMS) P220, P260, P604, P613, P614, 45, 45.2

Replication P313

Representational similarity analysis P425

reproductive affective disorder P540

reproductive psychiatry P679

Research domain criteria (RDoC) P50

resilience P13, P176, P396, 31.2

respiration P283

response inhibition P307

Resting and task fMRI 14.5, 33.1, P4

Resting State Connectivity P571, 14.2

Resting State Functional Connectivity P92, P228, P269, P367, P555, P556, P565, P579, P615, P662, P703, P746, P799, P836, P203, 3.3, P557, P559, P614, P892

Resting-state fMRI P2, P40, P415, P544, P563, P574, P816, P836, P846, P899, 35.5, 53

Resting-state MRI P547

retinoic acid P328

retrograde tracing P827

retrorubral field (A8) 50.2

Rett's Syndrome 24

reversal learning P470

Reward P198, P297, P407, P425, P453, P492, P653, P736, P754, P772, P773, P840, P892, P771, 44, 44.5

reward and aversion P316, P645, 15.3

Reward Anticipation P75, P198

reward circuitry P203, P272

Reward memory P768

Reward Motivation P448

reward motivation and decision-making 8.2

Reward network P4

reward prediction error P316

reward processing 14.3, 39.2

Reward seeking P763, P769, P775, P767, 15.5, P491

Reward self-administration P480

Reward, motivation, and anhedonia P752, P759, P810, P892, P756, P761, 41.2, 39

Reward-based decision-making P408, P420, P537, P764, 44.4

RGS3 P460

rhesus macaques P742

Risk P297

Risk and Resilience P722, 39.1

Risk factors P739, 4.5

Risk Stratification P91

Risk-based decision making P322

risk-reward paradigm P758

Risk-taking P888

Risky decision-making P764, 44.4

R-ketamine P379

RMTg P365

RNA binding protein P467

RNA Sequencing P454, P499

RNA splicing P803

RNA therapeutics 49, 49.3

RNAseq P461, P500, P518, P539, P53, P839

RNA-sequencing P146, P774

Rodent models P301, 29.5, 41

Rodents P20, 50.3

roluperidone P167

rTMS P605

rumination P547

s100a10 P149

Safety P171, P684, P793, P796, P805, P230, P866

Safety/tolerability P692

Salience P316

Salience network P2

SAPAP3 KO mice P660

Schizophrenia (SCZ) P85, P96, P141, P168, P190, P268, P434, P441, P461, P487, P578, P622, P779, P784, P785, P787, P792, P798, P800, P802, P803, P814, P815, P818, P821, P823, P829, P834, P836, P838, P843, P844, P845, P847, P849, P850, P853, P854, P167, P174, P782, P806, P817, P826, P841, P29, P532, P786, P813, P816, P839, 17.4, 11, 17.2, 23.2, 47.4

schizophrenia negative symptoms P810

Schizophrenia novel treatment P622

Schizophrenia Spectrum Disorders P158, P613

Schizophrenia Spectrum Illness P191, P783, P790, P811, 4.4, 4.5, 11.5

Schizophrenia, Antipsychotics P652, P811, P853

Schizophrenia, Bipolar disorder, Depression P781

Schizophrenia, negative symptoms P780

Schizophrenia, synaptic aberrations P780

schizotypy P187

Scoring Accuracy P795

Seasonality P861

Seizure P620

Selective Serotonin Reuptake Inhibitors (SSRIs) P97, P767

self administration P293, P359

Self-control P180

self-harm P903

self-suggestion 43.3

Semaglutide P370

sensing 1.3

sensitization P359

sensorimotor P527

sensory processing P893

Serotonin P17, P54, P227, P453, P523, P584, P636, P637, P653, 18.1, 19.1

serotonin 1a receptor P263

serotonin 2A 19

Serotonin 5-HT2A Receptor 36.4

Serotonin 5-HT2C Receptor P349, P636

serotonin receptors P688

Serotonin Transporter P584

sex difference P144, P877, 46, 49.4, P363, P372, P512, P888, P7, P704, P77, P253, P292, P296, P359, P379, P385, P395, P401, P473, P490, P513, P533, P773, P867, 8, 8.1, 8.3, 18.1, 27.3, 29.3, 31.3, 35.2, 36.2, 42.3, 43.2, 46.3, 50.5

sex steroid hormone receptors P777

Sex-specific effects P388, P628, P764, P890, 12.2, 27.4, 46.4, 50

Sexual and gender minority P904

Sexual Dimorphism P72, P241

Sham-Controlled P601

shRNA 49.2

SH-SY5Y P509

sigma-1 receptor P421

signal transduction P787

Simulated Driving P621

single cell omics P667

single cell RNA-Seq P251

single cell sequencing 12

Single nucleus RNA sequencing P486, P823, P863, 42.5

Single Session P239

single-cell genomics P271, P719

Single-cell RNA sequencing P741, 30.2

single-cell sequencing 12.5

single-nucleus RNA-sequencing P151

Single-unit electrophysiology in vivo P638

Skin conductance responses P716, 35.4

sleep P133, P737, P855, P857, P864, P383, 34.5, 38.2

sleep and fatigue P256

sleep architecture P318

sleep deprivation 54, 54.3

Sleep disturbances P9, P33, P270, P294, P332, P345, P822, P856, P858, P862, P860, 54.2

sleep homeostasis P855

Sleep inconsistency P415

slice electrophysiology P138, P289, P365, P444, P645, P753, P827, 29.4

slow-wave activity P867

smartphone P38, P856, P902

Smell P582

Smoking P354

Smoking Cessation P440

SNPs P120, P130

snRNA-seq P204

Sociablility P29

Social and behavioral deficits P513

social anhedonia P856

social anxiety disorder P56, P566

social attachment P665

Social Behavior P16, P156, P304, P449, P450, P473, P665, P703, P868, P870, P871, P872, P874, P875, P876, P906, P74, 35.2

social bond P873

Social brain P526

Social buffering P290, P824

social cognition P309, P423, P487, P613

social cognitive skills training P168

Social communication P21

Social defeat stress P877

social determinants of health P531

Social Factors and Functioning P175

Social Feedback P464

Social Functioning P117, P844, P870, 33.4

Social Impact P671

Social incentive learning P156

social interaction P290, P353, P520, P870

social isolation P340, P450, P785, P878

Social media language 1.2

Social Media Use P9

social motivation P117

social neuroscience P166, P558

Social Processing P50

Social reward P270, P755

social salience P877

social stress P785

Social Support P413, P879

Social Threat P31, P904

social touch P844

Social Trauma P625

social withdrawal P836

Somatosensory processing P489

Somatostatin P47, P700, 51.3

Somatostatin-expressing interneurons P768

spatial memory P535, P889

Spatial Navigation P466

spatial transcriptomics P235, P667, P151, P506, 42.5

speech P41

sphingosine 1-phosphate receptor P150

Spinal Cord P489

SSRIs P586, P437, 15.5

statistical methods P64, P78, P598

Sterol Biosynthesis P28

Stimulants P438, P238

stratified precision medicine trial 48.4

Stress P178, P213, P372, P413, P668, P772, P345, P538, 31

Stress and Trauma P725

stress disorders 54

stress hormones P469

stress in adolescence P26

stress resilience and susceptibility P492

stress-enhanced fear learning (SEFL) P695

Stress-resilience P246, P720

Striatal Dopamine signaling P143, P485, P757, 44.2

striatal functional connectivity 53.1

Striatum P839, 33

Structural and Functional Connectivity P838

structural and functional MRI P575

Structural MRI P5, P105, P418, P527, P560, P720, 4.4

structural neuroimaging P529, P562

structural neuroplasticity P707

structure-activity relationships P142

Subcallosal Cingulate 20.4, 28.4

subcortical volume P247

subgenual anterior cingulate cortex P781

Subjective Cognitive Impairment P169

Subjective Response P339, P382, P565

subphenotypes 23.2

Substance abuse disorders P295, P302, P760

substance use P405

substance use disorder P102, P352, P366, P385, P387, P639, 54.2, P142, P148, P298, P357, P627, P669, 1.3, 5, 24, 40, 54

Substance use disorder treatment 1.2

Substance Use Initiation P6, P280

Subtypes of substance use disorder 13.3

Subtyping P6

Suicidal behavior P222

suicidal ideation P248

Suicidality P101, P901, 39.1

suicide P270, P896, P902, P904, P906, P911, P129

Suicide Assessment P911

Suicide attempt P897, P905, P907, P908

Suicide Mechanisms P909, P910, P912

Suicide prediction P899, P903, 9

suicide prevention P833, 9

Suicide Risk P261

Suicide risk factors P655, P833, P900, P903, P905, P907, P910, 9

surface area P568

surgery 8.2

SV2A PET Imaging Study 23.2, 30, 30.3

SV2A protein P358

symptom mapping P789

synapses 30.2

synaptic density P397, P576, 23, 23.2, 23.4

Synaptic Function 46.2

synaptic physiology P444

Synaptic Plasticity P81, P153, P208, P215, P249, P386, P512, P144, P384

synaptic plasticity, epigenetic, gene expression P346

Synaptic protein imaging 23.3

Synaptic Vesicle Glycoprotein 2A (SV2A) P261, P576

synchrony P873

Synthesis P40

systematic review P685

systemic inflammation P790

systems biology 12.3

systems neurobiology P787

Tachykinin 51.4

tachyphylaxis P161

tACS P239, P850

Target engagement 47

targeted cognitive training P90, P174

Targeted interventions P286

task connectivity P813

task fMRI 44.5

Taste P582

tau P506

TDCS P734

telemetry P857

Testosterone P888, P1

Test-Retest Reliability P286

Th17 cells 3.2

Thalamus P527, P609

THC P107, P391, P426, P571, P642, P891, 21.2, 29

The Columbia-Suicide Severity Rating Scale (C-SSRS) P898

theory of mind 21.3

Therapeutic alliance 7.5

Therapeutic Development P643

therapeutic targets 17.3

theta band oscillatory measures P825, P848

theta burst transcranial magnetic stimulation P196, P260

Theta-burst stimulation P109, P556, 45, 45.3

Threat P567, P754

Threat Conditioning 50.2, 54.1, P462

threat detection P463

Threat reactivity 15.2

thyroid hormone P337

tianeptine 15.4

Tic disorders P660

Tight junction protein P588

time-frequency P848

timing P681

Tirzepatide P223

TMS P83, P89, P198, P601, P606, P612, P717, P814, P829, 33, 33.3, 45.1, 45.4

TMS frequencies P569

TMS-EEG P79, P88, P800

TNF-alpha antagonist P203

Tobacco P347

tobacco use P403

Tolcapone P158, P649

Tolerability P210

tolerance P161

Toll-Like receptor 9 (TLR 9) P74

Tourette syndrome P534, P656

Toxicity P65

Toxoplasma P593

transcranial alternating current stimulation P212

transcranial direct current stimulation (tDCS) P603, P804, P616

transcranial magnetic stimulation (TMS) P296, P542, P569, P598, P846, P534, P615

transcranial photobiomodulation P602

transcript isoforms P803

transcription P22

Transcriptome P148, P357, P743, P891

Transcriptomics P235, P419, P446, P523, P781, P823, P201

Transdiagnostic P90, P108, P899, 37.3, 38.1

Transdiagnostic biology P191

Transformer 7.2

transgenerational P400

transitional age youth P592

Translational Animal Models 10.2, 54, P126

Translational biomarker approaches to drug development P86

translational biomarker development P81

Translational Neuroscience P296, P705, P806

Translational research P48, P304, P430, P733

translational science P147

Translational studies P522

Translocator Protein Distribution Volume P570

Transposable element P375

trauma P13, P840, P900

trauma and stress disorders P701

Trauma exposure P352, P699, P703, P731, P732

trauma memory P711

Traumatic Brain Injury P682

Traumatic stress 37

trazadone P866

TRD P171, P686, 10.3

Treatment mechanisms 14

Treatment Prediction P34

treatment resistance P240, P200

Treatment Resistant Depression P222, P553, P589, P648, P694, P248, P605, P689, 28.4, P105, P162, P546, P690, P245

Treatment resistant schizophrenia P782, P845, P808, P853

Treatment Selection P209

treatment-resistant Major Depressive Disorder P443

Treatment-Response P97, P100, P705, P843

Triazole compounds P302

Tryptophan catabolites (TRYCAT) P860

TSND-201 P726

TSPO 30

Two-photon calcium imaging P760

Type 1 corticotropin releasing factor receptor P7

Type-2 Diabetes P701

ubiquitination P460

UK Biobank/AURORA P82

Ultra-high field MRI P242

Ultrasonic vocalization (USV) model P68

uncertainty P185, P493, P545, P840

Under-represented minorities 16

Unmedicated P816

unpredictability P25

Urgency P2

vagus P361

vagus nerve stimulation P384

valence P479, P481

Valence assessment 15

Value-based Decision-Making P185, P186, P408, P779

vaping P334, P354

Vapor P381

Varenicline P334

vasopressin and oxytocin P449

Venlafaxine P456

ventral capsule/ventral striatum 28.3

ventral hippocampus P470, P490, 41.1

Ventral Pallidum P480, P481, P728, P774, P394

Ventral Striatum P66, P435, P476

Ventral Tegmental Area (VTA) P278, P333, P409, P444, P875, P448

veterans P43, P608, P734, P122, P689

Vicarious defeat stress P77

video methods 7.4

virtual reality P616

visual cortex P732

Visual plasticity P609

Visual Processing P51

visuospatial working memory P798

vitamin D P657

vmPFC P464

Volatile Organic Compounds P80

Volatility P193

VTA P771

Vulnerability P668

Vulnerability traits P702

Wearable Sensing P822

wearables P747

Weight loss treatment P541

Wellbeing P666

White Matter P521, P471

White matter hyperintensities P508

White matter microstructural alteration P578, P830

Whole exome sequencing P417

Whole-Brain Rodent Imaging P306, P893, 17.4

Williams syndrome P518

withdrawal P161

working memory P61, P187, P325, P468, 21.3

World Trade Center responders P720

Xanomeline P793, P796, P805

xCT P647

Xylazine P294, P318, P336, P360

Yohimbine P889

young adults P904, 21.2

youth P111, P905, 14.4

zebrafish P503, P65

Zinc P650

α5-GABAAR P213